Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects (Q72422185)
Jump to navigation
Jump to search
scientific article published on 01 October 1994
Language | Label | Description | Also known as |
---|---|---|---|
English | Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects |
scientific article published on 01 October 1994 |
Statements
Biochemotherapy with thymosin alpha 1, interleukin-2 and dacarbazine in patients with metastatic melanoma: clinical and immunological effects (English)
M Lopez
S Carpano
R Cavaliere
L Di Lauro
F Ameglio
G Vitelli
A M Frasca
P Vici
F Pignatti